Radiopharma companies merge after one receives surprise FDA rejection - STAT
Source: STAT ·
Radiopharma companies merge after one receives surprise FDA rejection STATAnalysts ‘extremely bullish’ as Telix beams into Novartis’ territory with $1.6B ITM acquisition Fierce BiotechTLX: US$1.65B acquisition creates a global radiopharmaceutical leader with major growth potential TradingViewTelix’s US$1.65 Billion ITM Deal Adds 105.8 Million Shares as Stock Falls 3% TechStock²Australian Shares…